National Beverage shares rose 6% after the LaCroix maker declared a special cash dividend of $3.25 per share following fiscal 2026 results that included net sales of $1.2 billion and earnings per share of $1.96. Can-Fite BioPharma fell 12% even as the company reported positive Phase 2a data for Namodenoson in advanced pancreatic cancer, with the trial meeting its primary safety endpoint and showing durable survival in heavily pretreated patients. Embraer slipped 5% after completing the acquisition of Safran Cabin's remaining 50% stake in the EZ Air Interior joint venture, giving the aircraft maker full ownership of the Mexico-based cabin interiors operation.
National Beverage CorpDeclared a special cash dividend of $3.25 per share after strong fiscal 2026 results.
Can Fite Biopharma Ltd ADR
Embraer S.A.